Epsilon Imaging’s Post

The Fall 2024-Winter 2025 issue of Catalyst is out, highlighting the latest news and developments at Lankenau Institute for Medical Research. Inside this issue: • Easing patients' battle with chemotherapy side effects • Working to turn superfood into supermedicine • Advanced imaging sets LIMR apart in cardiac research • Dr. Matt Finley becomes LIMR Vice President Read the issue: https://lnkd.in/eP6t_F8S

This session will review the evidence and utility of diagnostics in respiratory clinical practice, as well as the role of new imaging techniques and modalities in improving diagnosis and phenotyping. Learn more and book your ticket: tinyurl.com/ysemz7cp #BTSWinter2024

Surgical performance of minimally invasive esophagectomy (MIE) can be assessed with a competency assessment tool (CAT). The MIE-CAT correlates with surgical experience and patient outcomes and can be used for training, quality improvement, and research. https://ja.ma/3PpEVP3

Here, we investigated the haemodynamic significance of extrinsic outflow graft stenoses (eOGO) during HeartMate 3-therapy. This complication have provoked clinical apprehension and interventions and recently lead to a FDA Class 1 recall. The haemodynamic impact of a stenosis detected visually or by quantification of cross-sectional area reduction may be difficult to predict and easily overestimated. This numerical study suggests that, for clinically encountered flow rates and stenosis severities below 61% in cross-sectional area decrease, eOGO may have low haemodynamic impact. This suggests that patients without symptoms or signs consistent with haemodynamically significant obstruction might be managed expectantly. European Heart Journal Imaging Methods and Practice: https://lnkd.in/dBqhSYTV The result of a great collaboration: Mårten Sandstedt, Marianna Papagewrgiou, Anders Svensson, Ann Bolger, Éva Tamás, Hans Granfeldt, Tino Ebbers & Jonas Lantz

The clinical potential of liquid biopsies is rapidly evolving. As we gather with industry leaders, researchers, and healthcare professionals at the European Liquid Biopsy Society (ELBS)’s General Assembly, we aim to inspire and be inspired – sharing insights that can propel our industry forward. Together we can push the boundaries of what is possible. Learn more about our innovations in liquid biopsy: https://lnkd.in/eCxEBm-Z #LiquidBiopsy #CancerResearch #ELBS24

Thanks to Ehsan Samei for sharing this survey! Please, share this survey broadly with all patients or potential patients (all of us) whom you know, and also take the paired survey that is likewise designed for healthcare professionals!

Tune in tomorrow for updates on the latest technologies in #InterventionalCardiology! This webinar will equip you with a deep understanding of the CCTA + FFRCT pathway so you can assess its benefits and clinical impact. ➡️There is still time to register: https://lnkd.in/gyQ5ZAgM

Another fun collaboration with GIG Health. Considering a clinical trial can be an overwhelming decision, and not understanding what to expect with screening and assessments can add to that stress. Check out our new video describing how the North Star Ambulatory Assessment contributes to research and what to expect when going through the assessment with a clinician. #clinicaltrials #NSAA #musculardystrophy Edgewise Therapeutics

In an episode during Transform AF case series, Dr. Devi G Nair, MD, FACC, FHRS and Dr. John Day, discuss the transformative potential of fluoroscopy-free cardiac procedures. Here are some key points; Pre-mapping is primarily reserved for complex cases, such as redo procedures or anatomically challenging interventions, rather than standard anatomical ablations. Decisions about mapping tools, like high-density catheters, are influenced by cost constraints without compromising safety or procedural outcomes. Intracardiac echocardiography (ICE) plays a critical role in fluoroscopy-free procedures, providing real-time visualization and reducing reliance on additional mapping tools. Reducing or eliminating fluoroscopy enhances safety by decreasing radiation exposure for both patients and clinicians, without affecting procedural efficacy. A steep learning curve is associated with fluoroscopy-free workflows, but experience enables clinicians to streamline processes and achieve optimal results. #EPEEPS Boston Scientific

Delving into cutting-edge research, Scott Goates, member of MDIC's Science of Patient Input Steering Committee, collaborated on a groundbreaking study contrasting transcatheter and surgical mitral valve repair. This study underscores the critical role of integrating #patientpreference data with clinical outcomes, aligning with FDA's Patient Preference Initiative. Uncover the insights in the research published in JAHA — Journal of the American Heart Association. Read more at https://lnkd.in/eJyX_xNQ